NCT05505721

Brief Summary

The aim of the study is to examine the relationship between the nutritional content of the diet consumed by children and adolescents (0-18 years old) with the diagnosis of type 1 diabetes and metabolic control. In this cross-sectional study, 150 children and adolescents with type 1 diabetes who came to Ege University Child Health and Diseases Department, Pediatric Endocrine and Diabetes Department for regular check-ups (4 diabetes control/year) and kept food consumption records in the last 1 year will be included. Body weight and height measurements of the cases will be done by the same person in Ege University Pediatric Endocrinology and Diabetes BD Polyclinic. Turkish Standard Institute approved Baster brand weighing instrument with 0.1 kg intervals and height measurements will be made with Harpander brand stadiometer with 0.1 cm intervals. SD scores of body weight, height and body mass index for age Neyzi et al. It will be calculated using the reference values developed for Turkish children by Age, diabetes age, gender, height - body weight-body mass index SD score, HbA1c level, daily energy intake, percentage of energy from carbohydrate-protein-fat-saturated fat in energy, daily fiber intake amount of the cases will be recorded in the case report form. The biochemical values of the participants will be taken from the file records. The data will be entered into the statistical package program and the patients' 1) carbohydrate, protein, fat, saturated fat intake, 2) vitamin-mineral intake, and 3) fruit and vegetable consumption will be compared with the recommendations in national and international guidelines and their relationship with metabolic control will be investigated

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
130

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2021

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 16, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 16, 2022

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

June 17, 2022

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 18, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2022

Completed
Last Updated

February 28, 2023

Status Verified

February 1, 2023

Enrollment Period

1 year

First QC Date

June 17, 2022

Last Update Submit

February 25, 2023

Conditions

Keywords

type 1 diabeteschildrenadolescentsdiet

Outcome Measures

Primary Outcomes (5)

  • Macronutrient distribution

    The macronutrient distribution of participant's diets will be evaluated for compliance with national and international guidelines.

    day 1

  • HbA1c

    As metabolic control parameter

    day 1

  • Height (m),

    As a growth monitoring parameter

    day 1

  • Weight (kg)

    As a growth monitoring parameter

    Day 1

  • Body mass index (kg/m2)

    As a growth monitoring parameter

    Day 1

Eligibility Criteria

Age1 Month - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Diabetes treatment, cases followed in Ege University Pediatrics Department, Pediatric Endocrine and Diabetes Department

You may qualify if:

  • who came to regular check-ups in the last 1 year (4 diabetes checks/year)
  • children and adolescents who keep a food diary for 3 days before coming to diabetes control by their own/caregiver

You may not qualify if:

  • Cases that do not accept to fill in the 'Informed Consent Form'
  • Cases with diseases accompanying T1DM (autoimmune diseases such as celiac, cystic fibrosis, etc.)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Ege University

Izmir, Bornova, 35100, Turkey (Türkiye)

Location

Ege University Faculty of Medicine Department of Pediatrics

Izmir, 35100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 1

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • yelda mansuroglu, MSc

    Ege University

    STUDY CHAIR
  • gunay demir, MSc

    Ege University

    STUDY CHAIR
  • samim ozen, Assoc Prof

    Ege University

    STUDY CHAIR
  • sukran darcan, Prof Dr

    Ege University

    STUDY CHAIR
  • damla goksen, Prof Dr

    Ege University

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

June 17, 2022

First Posted

August 18, 2022

Study Start

March 16, 2021

Primary Completion

March 16, 2022

Study Completion

October 31, 2022

Last Updated

February 28, 2023

Record last verified: 2023-02

Locations